Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants

Je-Wook Yu1, Teresa Fernandes-Alnemri, Pinaki Datta

  • 1Department of Biochemistry and Molecular Biology, Center for Apoptosis Research, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Molecular Cell
|October 30, 2007
PubMed

Insights

Mutations in PSTPIP1 cause PAPA syndrome by overactivating pyrin. This protein complex assembly leads to inflammasome activation, explaining the autoinflammatory condition.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • PAPA syndrome is an autoinflammatory disease linked to mutations in PSTPIP1.
  • The precise molecular mechanisms underlying PSTPIP1-mediated autoinflammation remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanism by which PSTPIP1 mutations lead to PAPA syndrome.
  • To investigate the interaction between PSTPIP1 and pyrin in inflammasome activation.

Main Methods:

  • Biochemical assays to study protein-protein interactions.
  • Analysis of pyrin oligomerization and activation.
  • Characterization of PSTPIP1 mutants in pyrin activation.

Main Results:

  • PSTPIP1 is required for the assembly of the ASC pyroptosome, which activates caspase-1.
  • Pyrin acts as a cytosolic receptor for PSTPIP1, existing in an autoinhibited state.
  • PSTPIP1 binding unmasks pyrin's PYD, facilitating ASC interaction and pyroptosome formation.
  • PAPA-associated PSTPIP1 mutants exhibit enhanced pyrin binding and activation.

Conclusions:

  • Constitutive activation of pyrin by mutant PSTPIP1 proteins drives the autoinflammatory phenotype in PAPA syndrome.
  • The PSTPIP1-pyrin interaction is a critical step in inflammasome activation and PAPA pathogenesis.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...